He aha te Bictegravir-Emtricitabine-Tenofovir Alafenamide: Ngā Whakamahinga, te Inenga, ngā Pānga taha me ētahi atu
He aha te Bictegravir-Emtricitabine-Tenofovir Alafenamide: Ngā Whakamahinga, te Inenga, ngā Pānga taha me ētahi atu

Health Library

He aha te Bictegravir-Emtricitabine-Tenofovir Alafenamide: Ngā Whakamahinga, te Inenga, ngā Pānga taha me ētahi atu

October 10, 2025


Question on this topic? Get an instant answer from August.

Ko te Bictegravir-emtricitabine-tenofovir alafenamide he rongoā HIV whakakotahi e āwhina ana ki te pupuri i te huaketo i roto i tō tinana. E whakakotahi ana tēnei pire kotahi i ngā rongoā kaha e toru e mahi ngātahi ana ki te ārai i te HIV mai i te whakanui me te horapa puta noa i tō pūnaha. Kei te mōhio pea koe ki tēnei rongoā i tōna ingoa waitohu ko Biktarvy, ā, i hangaia hei whakamāmā i te rongoā HIV mā te whakauru i ngā mea katoa e hiahia ana koe ki roto i tētahi papa kotahi i ia rā.

He aha te Bictegravir-Emtricitabine-Tenofovir Alafenamide?

Ko tēnei rongoā he pire whakakotahi e toru-i-tētahi e rongoā ana i te mate HIV. Kei ia papa te bictegravir (50mg), emtricitabine (200mg), me te tenofovir alafenamide (25mg) e mahi ana hei tīma ki te whawhai i te huaketo. Whakaarohia me te mea e toru ngā raka rerekē kei runga i tō tatau - e aukati ana ia whakauru i te HIV i tētahi ara rerekē, e uaua ana ki te huaketo te pā i ngā raruraru.

Ko te huarahi whakakotahi te tikanga me tango noa koe i tētahi pire i ia rā hei utu mō te maha o ngā rongoā motuhake. Mā tēnei ka māmā ake te piri ki tō mahere rongoā me te whakaiti i te tūponotanga o te ngaro i ngā inenga. Ka tohutohu tō tākuta i tēnei hei wāhanga o te hōtaka rongoā HIV katoa.

He aha te Bictegravir-Emtricitabine-Tenofovir Alafenamide e whakamahia ana mō?

E rongoā ana tēnei rongoā i te mate HIV-1 i roto i ngā pakeke me ngā tamariki e taumaha ana i te iti rawa 25 kirokaramu (tata ki te 55 pauna). E whakamahia ana mō te hunga e tīmata ana i te rongoā HIV me te hunga e hiahia ana ki te huri mai i ētahi atu rongoā HIV. Ko te whāinga he whakaiti i te nui o te HIV i roto i tō toto ki ngā taumata e kore e kitea, e tiaki ana i tō pūnaha ārai mate me te ārai i te tuku ki ētahi atu.

He maha ngā tākuta e whakahau ana i tēnei rongoā nā te mea he tino whai hua, ā, he pai te aro ki te nuinga. He tino āwhina mō te hunga e hiahia ana ki te whakamāmā i tā rātou mahinga rongoā, ki te hunga rānei i pā ki ngā pānga taha i ētahi atu rongoā HIV. Mā tō tākuta e whakatau mēnā he tika tēnei huinga mō tō āhuatanga motuhake.

Me pēhea te mahi a Bictegravir-Emtricitabine-Tenofovir Alafenamide?

E mahi ana tēnei rongoā mā te aukati i te HIV i ngā wāhanga rerekē o tōna huringa ora. He aukati integrase a Bictegravir e aukati ana i te HIV mai i te whakauru i ōna rauemi ira ki roto i ō pūtau hauora. Ko Emtricitabine me tenofovir alafenamide he aukati nucleoside reverse transcriptase e ārai ana i te HIV mai i te hanga i ngā tārua o ia anō.

Tahi, ka hangaia e ēnei kai e toru tētahi arai kaha ki te whakanui i te HIV. Ki te kore e taea e te huaketo te whakaputa uri, ka tino heke te nui o te HIV i roto i ō toto. E kiia ana he huinga rongoā kaha tēnei nā te mea e whakaeke ana i te HIV mā ngā ara maha i te wā kotahi, e uaua ai te huaketo ki te whakawhanake i te ātete.

Kāore te rongoā e rongoā i te HIV, engari ka taea e ia te whakaiti i te huaketo ki ngā taumata e kore e kitea i roto i ō toto. Ki te kore e kitea te HIV, ko te tikanga e kore e taea e koe te tuku i te huaketo ki ō hoa moe, ā, ka taea e tō pūnaha ārai mate te ora, te noho hauora hoki.

Me pēhea taku tango i te Bictegravir-Emtricitabine-Tenofovir Alafenamide?

Tangohia tētahi papa mā te waha kotahi i te rā, me te kai, me te kore rānei. Ka taea e koe te tango ki te wai, te wai hua rānei, te miraka rānei - ahakoa te mea e pai ana ki a koe. Whakamātau ki te tango i te wā kotahi i ia rā hei āwhina i a koe ki te mahara me te pupuri i ngā taumata rongoā i roto i tō tinana.

Kāore koe e hiahia ki te kai i mua i te tango i tēnei rongoā, engari he māmā ake ki ētahi tāngata ki tō rātou puku ina tangohia me te kai. Mēnā ka pā ki a koe te puku, ngana ki te tango me te paramanawa māmā, te kai rānei. Horomia te papa katoa - kaua e kuru, e ngaungau, e whati rānei, nā te mea ka pā tēnei ki te mahi o te rongoā.

Mēnā kei te tango koe i ngā antacids, ngā taapiri konupūmā, ngā taapiri rino rānei, wehea kia 2 hāora te wā i waenga i a rātou me tēnei rongoā. Ka taea e ēnei te whakararu i te pai o te ngāwari o tō tinana i te rongoā HIV. Ka taea e tō kaimātai rongoā te āwhina i a koe ki te whakamahere i te wā pai mō ō rongoā katoa.

Kia Pēhea te Roa o taku Tango Bictegravir-Emtricitabine-Tenofovir Alafenamide?

Me tango tonu e koe tēnei rongoā kia mau tonu te HIV. He herenga mō te oranga te rongoā HIV, ā, mā te whakamutu i te rongoā ka taea e te huaketo te whakaputa ano i te tere. He maha ngā tāngata e haere tonu ana ki te tango i tēnei rongoā mō ngā tau, i te wā e whai hua ana, e pai ana hoki.

Ka aroturuki tō tākuta i tō ahunga whakamua mā ngā whakamātautau toto i te wā katoa hei tirotiro i tō uta huaketo me te tatau pūtau CD4. Ka āwhina ēnei whakamātautau ki te whakatau i te pai o te mahi o te rongoā. Mēnā ka kore e kitea tō uta huaketo, ka noho pērā, he tohu tēnei kei te pai te mahi o te rongoā.

Kaua rawa e mutu te tango i tēnei rongoā me te kore e kōrero ki tō tākuta i te tuatahi. Ahakoa e tino hauora ana koe, ko te rongoā te mea e ārai ana i te huaketo. Ka mahi tō rōpū hauora ki a koe ki te whakatika i ngā āwangawanga katoa me te whakarite kia taea e koe te haere tonu i te rongoā i te angitu.

He Aha ngā Pānga taha o Bictegravir-Emtricitabine-Tenofovir Alafenamide?

He pai te ngāwari o te nuinga o ngā tāngata ki tēnei rongoā, engari pērā i ngā rongoā katoa, ka taea e ia te pānga taha. Ko te rongo pai he mea noa ngā pānga taha nui, ā, he tokoiti ngā tāngata e pā ana ki ētahi raruraru i te wā e tango ana.

Anei ngā pānga taha tino noa ka pā ki a koe, ahakoa he maha ngā tāngata kāore he raruraru:

  • Te mamae o te upoko
  • Te korere
  • Te whakapairuaki
  • Te ngenge, te ngenge rānei
  • Te pororaru
  • Te raruraru ki te moe
  • Ngā moemoeā rerekē

Ko ēnei pānga taha he ngawari noa iho, ā, he maha ngā wā ka pai ake i roto i ngā wiki tuatahi i te wa e urutau ana tō tinana ki te rongoā. Mēnā ka mau tonu, ka pōuri rānei i a koe, kōrero ki tō kaiwhakarato hauora mō ngā huarahi hei whakahaere i a rātou.

Ko ētahi pānga taha kāore i te pōturi engari he nui ake te kino e hiahia ana kia āta tirohia e te tākuta. Ahakoa he onge ēnei, he mea nui kia mōhio koe ki a rātou:

  • Te pōuri nui, ngā whakaaro whakamomori rānei
  • Ngā raruraru tākihi nui (te iti o te mimi, te pūhi, te rangirua)
  • Ngā raruraru wheua (te mamae wheua rerekē, ngā whati)
  • Ngā raruraru ate (te kōwhai o te kiri, o ngā kanohi rānei, te mimi pouri, te mamae puku nui)
  • Te waikawa lactic (te mamae uaua rerekē, te raruraru ki te manawa, te mamae puku, te pororaru)

Whakapā atu ki tō tākuta i te wā tonu mēnā ka pā ki a koe ētahi o ēnei tohumate nui. Ahakoa kāore i te pōturi, he mea nui te mōhio wawe me te rongoā mō tō haumaru me tō oranga.

Ko wai kāore e tika kia tango Bictegravir-Emtricitabine-Tenofovir Alafenamide?

Kāore tēnei rongoā i te tika mō te katoa, ā, ka āta arotake tō tākuta i tō hītori hauora i mua i te whakahau. Kāore koe e tika kia tango i tēnei rongoā mēnā he pānga tō mate pāwera ki ōna kai, mēnā rānei he mate tākihi nui tō.

Ko ngā tāngata e whai ana i ētahi āhuatanga hauora e hiahia ana kia āta aroturukihia, ā, me whakamahi rānei i tētahi rongoā HIV rerekē. Ka tino āta tū tō tākuta mēnā kei a koe:

  • Te mate tākihi, te iti rānei o te mahi tākihi
  • Te mate ate, tae atu ki te hepatitis B, C rānei
  • Ngā raruraru wheua, te hītori rānei o ngā whati
  • Te pōuri, ētahi atu āhuatanga hauora hinengaro rānei
  • Te mate ngākau

Mēnā he mate pūkahukahu B tō, ka mōrearea te pūkahukahu ki te pōrearea nui mēnā ka mutu ohorere tēnei rongoā. Ka mātakitaki tō tākuta i a koe, ā, tērā pea ka whakahau rongoā anō hei tiaki i tō ate.

Ka taea e ngā wahine hapū te tango i tēnei rongoā, engari he mea nui kia kōrerohia ngā tūponotanga me ngā painga ki tō kaiwhakarato hauora. Ka taea e te rongoā te uru ki te waiu u, nō reira me āta whakatau i ngā whakatau whāngai u me te āwhina hauora.

Ingoa Waitohu Bictegravir-Emtricitabine-Tenofovir Alafenamide

Ko te ingoa waitohu mō tēnei rongoā whakakotahi ko Biktarvy. I hangaia e Gilead Sciences, ā, i whakaaetia e te FDA i te tau 2018. Tērā pea ka kite koe i tēnei rongoā e kīia ana e tōna ingoa waitohu, e ōna wāhanga whānui rānei.

Kei te wātea a Biktarvy hei papa porowhita, āhua papura, kua tohua ki te

He tino whai hua ngā momo rongoā e rua ki te whakahaere i te HIV, ā, ko te kōwhiringa "pai ake" ka whakawhirinaki ki ō āhuatanga takitahi. Ko ngā hōtaka e whai ana i te bictegravir pēnei i te Biktarvy me ngā hōtaka e whai ana i te dolutegravir pēnei i te Triumeq e rua e kiia ana he maimoatanga tuatahi e ngā aratohu maimoatanga HIV.

He pai ake pea te Biktarvy i te mea he iti ake ngā pānga o te rongoā me te iti ake pea te pikinga o te taumaha ki ētahi hōtaka e whai ana i te dolutegravir. Heoi anō, kua roa kē te whakamahi i ngā huinga e whai ana i te dolutegravir, ā, he nui te wheako tūturu. He kōwhiringa pai ēnei e rua mō te nuinga o te hunga e tīmata ana i te maimoatanga HIV.

Ka whakaarohia e tō tākuta ngā āhuatanga pēnei i ō rongoā kē atu, ō āhuatanga hauora, me ō hiahia whaiaro i te wā e whiriwhiri ana i waenga i ēnei kōwhiringa. He nui te angitu o ngā hōtaka e rua ki te whakatutuki me te pupuri i ngā uta viral e kore e kitea.

Ngā Pātai Auau mō Bictegravir-Emtricitabine-Tenofovir Alafenamide

Q1. He Haumaru te Bictegravir-Emtricitabine-Tenofovir Alafenamide mō te Hunga e Mate ana i te Whatumanawa?

Ka taea te whakamahi i tēnei rongoā mō te hunga e pā ana ki te mate whatumanawa ngawari ki te āhua, engari me mātakitaki pai. Ka tirohia e tō tākuta tō mahi whatumanawa i ngā wā katoa mā ngā whakamātautau toto, ā, ka whakatikatika pea i tō mahere maimoatanga ki te hiahiatia. Kāore te hunga e pā ana ki te mate whatumanawa nui (te whakawātea i te creatinine iti iho i te 30 mL/min) e tika ana kia tango i tēnei rongoā.

He ngawari ake te wāhanga tenofovir alafenamide ki ngā whatumanawa i ngā momo tenofovir tawhito, e waihanga ana i tēnei huinga hei kōwhiringa pai mō te nuinga o te hunga e pā ana ki te whatumanawa. Heoi anō, ka whakatauria e tō kaiwhakarato hauora ngā painga me ngā tūponotanga i runga i tō mahi whatumanawa motuhake.

Q2. Me Pēhea Taku Mahi ki te Tango Ahau i te Nui Rawa o Bictegravir-Emtricitabine-Tenofovir Alafenamide?

Mēnā ka inu koe i te rongoā nui atu i te kotahi i te rā, whakapā atu ki tō tākuta, ki te kaimātai rongoā rānei mō te tohutohu. Kāore pea he kino nui ka puta mēnā ka inu koe i te horopeta anō i ētahi wā, engari he mea nui kia whiwhi tohutohu hauora. Kaua e ngana ki te "whakatika" i te horopeta anō mā te karo i tō horopeta e whai ake nei.

Mēnā i inu koe i te nui atu i te mea i tohua, i te kore rānei e pai ana koe i muri i te inu i te rongoā anō, rapua tonu te āwhina hauora. Kia mōhio ki te wā me te nui i inu ai koe hei āwhina i ngā kaiwhakarato hauora ki te tuku i te tohutohu pai rawa atu ki a koe.

Q3. Me pēhea ahau ki te kore e inu i te horopeta o Bictegravir-Emtricitabine-Tenofovir Alafenamide?

Mēnā ka ngaro koe i tētahi horopeta, inumia i te wā e mahara ana koe i te rā kotahi. Mēnā kua tata te wā mō tō horopeta e whai ake nei (i roto i te 12 hāora), karohia te horopeta i ngaro, ka inu i tō horopeta e whai ake nei. Kaua rawa e inu i ngā horopeta e rua i te wā kotahi hei whakatika i tētahi horopeta i ngaro.

Ngana ki te hoki ki tō wāhanga rānei i te wā e taea ai. Kāore pea te ngaro i ngā horopeta i ētahi wā e puta he raruraru tonu, engari ko te ngaro i ngā horopeta i ngā wā katoa ka taea e te HIV te whakawhanake i te ātete ki te rongoā. Whakaarohia te whakatakoto i ngā whakamaharatanga waea, te whakamahi rānei i tētahi kaiwhakarite pire hei āwhina i a koe ki te mahara.

Q4. Āhea ahau e mutu ai te inu i te Bictegravir-Emtricitabine-Tenofovir Alafenamide?

Kaua rawa koe e mutu te inu i tēnei rongoā me te kore e kōrero ki tō tākuta i te tuatahi. He roa te rongoā HIV, ā, ko te mutu i te rongoā ka taea e te huaketo te whakanui anō i te tere. Ahakoa te kore e kitea tō uta viral, ā, e pai ana koe, ko te rongoā te mea e ārai ana i te huaketo.

Ka whakaaro pea tō tākuta ki te huri i tō rongoā mēnā ka pā ki a koe ngā pānga taha, mēnā rānei ka puta ētahi atu āhuatanga hauora, engari ka uru tēnei ki te huri ki tētahi atu tikanga HIV, kaua ki te mutu i te rongoā katoa. Ko te whāinga tonu ko te pupuri i te aukati HIV whai hua.

Q5. Ka taea e au te inu waipiro i te wā e inu ana au i te Bictegravir-Emtricitabine-Tenofovir Alafenamide?

He pai te inu waipiro i te wa e tango ana i tenei rongoa, engari he pai ake te korero ki to kaiwhakarato hauora mo o tikanga inu. Karekau he pānga tika o te waipiro ki enei rongoa HIV, engari ka pā te inu nui ki tō ate me te hauora whānui.

Mena he raruraru tō ate, tae atu ki te hepatitis B, C rānei, ka tohutohu pea tō tākuta kia whakawhāitihia, kia karohia rānei te waipiro. Kia mahara ko te noho hauora whānui ka pai ake te mahi o tō rongoa HIV, ka whakaiti i te tūponotanga o ngā raruraru.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room immediately.

Health Companion
trusted by 6M people

Get clear medical guidance
on symptoms, medications, and lab reports.

Your health journey starts with a single question

Download August today. No appointments. Just answers you can trust.

Hand reaching for August Health app icon